286 related articles for article (PubMed ID: 16767709)
21. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
[TBL] [Abstract][Full Text] [Related]
22. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
23. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
24. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
[TBL] [Abstract][Full Text] [Related]
25. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences.
Kozlowski P; Chang SD; Goldenberg SL
Magn Reson Imaging; 2008 Jan; 26(1):72-6. PubMed ID: 17566687
[TBL] [Abstract][Full Text] [Related]
28. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
30. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
31. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
Moman MR; van den Berg CA; Boeken Kruger AE; Battermann JJ; Moerland MA; van der Heide UA; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):741-6. PubMed ID: 19804948
[TBL] [Abstract][Full Text] [Related]
32. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
[TBL] [Abstract][Full Text] [Related]
33. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
Miao H; Fukatsu H; Ishigaki T
Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
[TBL] [Abstract][Full Text] [Related]
35. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
36. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
37. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Taupitz M; Böhmer D; Beyersdorff D
Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
[TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.
Padhani AR; Gapinski CJ; Macvicar DA; Parker GJ; Suckling J; Revell PB; Leach MO; Dearnaley DP; Husband JE
Clin Radiol; 2000 Feb; 55(2):99-109. PubMed ID: 10657154
[TBL] [Abstract][Full Text] [Related]
39. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
[TBL] [Abstract][Full Text] [Related]
40. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
